FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0

R. Boellaard, M. O'Doherty, W. Weber, F. Mottaghy, M. Lonsdale, S. Stroobants, W. Oyen, J. Kotzerke, O. Hoekstra, J. Pruim, P. Marsden, K. Tatsch, C. Hoekstra, E. Visser, B. Arends, F. Verzijlbergen, J. Zijlstra, E. Comans, A. Lammertsma, A. Paans, A. Willemsen, T. Beyer, A. Bockisch, C. Schaefer-Prokop, D. Delbeke, R. Baum, A. Chiti and B. Krause

Department of Nuclear Medicine and PET Research, VU University Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. r.boellaard@vumc.nl
Jan, 2010



The aim of this guideline is to provide a minimum standard for the acquisition and interpretation of PET and PET/CT scans with [18F]-fluorodeoxyglucose (FDG). This guideline will therefore address general information about[18F]-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) and is provided to help the physician and physicist to assist to carrying out,interpret, and document quantitative FDG PET/CT examinations,but will concentrate on the optimisation of diagnostic quality and quantitative information.